North American fund launched by SGAM

SG Asset Management (SGAM) has launched a retail unit trust investing in North America.

Morningstar.co.uk Editors 12 June, 2001 | 4:22PM
Facebook Twitter LinkedIn

The SocGen American Growth unit trust is based on the institutional US equity fund that the firm launched three years ago. As with the institutional version, Alan Torry is lead fund manager, aided by Sam Mercer Nairne and Takouhi Tchertchian. Mr Torry also manages the SocGen Technology unit trust along with Hugh Grieves.

The unit trust will aim to outperform the S&P 500 by 1.5% a year after charges with a tracking error of 3-6%.

Mik Bates, the head of unit trust services and a director at SGAM, said, "The North American Growth fund will be at least 80% similar to the existing institutional fund. In terms of fundamentals the only difference between the two is that the new retail fund will have the scope to invest in Canada and Latin America as well as the US.”

“The fund will launch with a neutral weighting against the index in technology which is about 20%. The fund will stay within 6% of the index weightings in large sectors such as information technology, financials, and healthcare and within 3% in minor sectors such as materials, utilities and consumer staples.”

SGAM has launched nine retail funds, which currently have about £500m under management, since it was founded in January 1998.

Key details for the SocGen American Growth unit trust:

Untitled Document

Initial charge

5.25% (2% discount in the form of bonus units from June 11th-29th 2001)

Annual charge

1.5%

Minimum investment

Lump sum: £1,000;

Regular savers: £50 per month

Purchased as an ISA

Yes

PEP/ISA transfer

Yes

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

About Author

Morningstar.co.uk Editors  analyse and report on shares, funds, market developments and good investing practice for individual investors and their advisers in the UK.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures